- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04132167
Supervised Perturbation Training Results in Changes in Balance and Falling in Patients With Multiple Sclerosis
October 23, 2019 updated by: HATİCE YAKUT, Suleyman Demirel University
Physical exercise can prevent falls, certain types of exercise may be more effective.
Perturbation-based balance training is a novel intervention involving repeated postural perturbations aiming to improve control of rapid balance reactions.
The purpose of this study was to estimate the effect of perturbation- based balance training on falls and balance in daily life.Thirty patients with multiple sclerosis (PwMS) will assess with regard to dynamic balance, walking and falling.
Patients randomly will allocate to a personalized (PRG) or traditional (TRG) rehabilitation group.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Thirty patients with multiple sclerosis (PwMS) will assess with regard to dynamic balance, walking and falling.
Patients randomly will allocate to a personalized (PRG) or traditional (TRG) rehabilitation group.
Study Type
Interventional
Enrollment (Anticipated)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Isparta, Turkey
- Hatice Yakut
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 43 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- An age older than 18 years
- Stable phase of the disease without relapses or worsening in the last three months
- Referring fear of falling or a history of falls (at least one fall in the last year).
- Individuals with a high level of balance.
Exclusion Criteria:
- Psychiatric disorders
- Blurred vision
- Severe cognitive impairment
- Severely impaired upright postural control or limited participation in a rehabilitation program
- Cardiovascular and respiratory disorders.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: training group
perturbation balance training
|
exercises for body stability in different positions (bridge, sitting, quadrupedal, half- kneeling, kneeling, standing, monopodalic) performed with visual biofeedback; transfers training performed in front of a mirror; ambulation training with courses drawn on the ground in a straight line and with more complex tracks with visual controlin particular using the protocols seated balance/strength training, standing bal- ance/weight-bearing training, mobility training and closed-chain training;
|
Active Comparator: control group
traditional physical therapy that including strengthening and stretching
|
exercises for body stability in different positions (bridge, sitting, quadrupedal, half- kneeling, kneeling, standing, monopodalic) performed with visual biofeedback; transfers training performed in front of a mirror; ambulation training with courses drawn on the ground in a straight line and with more complex tracks with visual controlin particular using the protocols seated balance/strength training, standing bal- ance/weight-bearing training, mobility training and closed-chain training;
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
dynamic balance
Time Frame: 6 week
|
the effects of perturbation dynamic balance training assessed with four square step test >15 seconds = increased risk of falls
|
6 week
|
walking
Time Frame: 6 week
|
the effects of perturbation dynamic balance training assessed with 10 meter walking test
|
6 week
|
walking
Time Frame: 6 week
|
the effects of perturbation dynamic balance training assessed with time up and go test(TUG).A score of 30 seconds or more suggests that the person may be prone to falls
|
6 week
|
falling
Time Frame: 6 week
|
the effects of perturbation dynamic balance training assessed with Falling Efficacy Scale(FES).
The FES is a 10-item test.
On a scale from 1 to 10, with 1 being very confident and 10 being not confident at all.
|
6 week
|
fear of falling
Time Frame: 6 week
|
The short FES-I is a 7-item self-report questionnaire for measuring perceived self-efficacy to avoid a fall in various situations
|
6 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 20, 2018
Primary Completion (Anticipated)
October 20, 2019
Study Completion (Anticipated)
December 20, 2019
Study Registration Dates
First Submitted
November 23, 2017
First Submitted That Met QC Criteria
October 17, 2019
First Posted (Actual)
October 18, 2019
Study Record Updates
Last Update Posted (Actual)
October 25, 2019
Last Update Submitted That Met QC Criteria
October 23, 2019
Last Verified
October 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12345 (Danish Center for Healthcare Improvements)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsRecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Brigham and Women's HospitalMassachusetts General HospitalRecruitingMultiple Sclerosis | Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of MinnesotaMallinckrodtTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
Clinical Trials on perturbation training
-
Barzilai Medical CenterCompletedAccidental FallsIsrael
-
University of Illinois at ChicagoNational Institute on Aging (NIA)Completed
-
Barzilai Medical CenterCompletedAccidental FallsIsrael
-
Soroka University Medical CenterUnknown
-
Georgia State UniversityNational Institutes of Health (NIH); Alzheimer's AssociationRecruiting
-
Riphah International UniversityCompleted
-
Istanbul Arel UniversityRecruiting
-
National Taiwan University HospitalCompletedCervical MyelopathyTaiwan
-
University of Illinois at ChicagoEunice Kennedy Shriver National Institute of Child Health and Human Development...Recruiting
-
Aalborg University HospitalOdense University Hospital; University of Southern Denmark; Aalborg University; Aalborg MunicipalityCompleted